U.S. employers don't expect health reform to advance their goals. That's according to a recent survey conducted by Towers Watson. The survey found a major disconnect between employer priorities and the impact they anticipate the PPACA will have.
U.S. EMPLOYERS don't expect health reform to advance their goals. That's the sentiment expressed by 661 respondents in a recent survey conducted by Towers Watson, a global professional services company.
"Right now from an employer perspective, there's more of a focus on the burden of implementation," says Julie Stone, a senior consultant with Towers Watson. "Once they get past figuring out what they have to do for January 1, 2011, they need to figure out how to embrace the law and make it part of their strategy."
The survey found a major disconnect between employer priorities and the impact they anticipate the Patient Protection and Affordable Care Act (PPACA) will have.
Unfortunately, few expect reform legislation to advance those goals. In fact, 94% of respondents said they expect healthcare reform to increase their organization's healthcare costs. Respondents expect an excise tax on rich benefit plans-43% expect they will be subject to the tax-and the mandate to cover dependents up to age 26 to be primary cost drivers.
LESS PRESSING ISSUES
But cost isn't the only employer priority the legislation fails to address, they say. Most (61%) believe the law won't do anything to encourage healthier lifestyles, improve quality of care (46%) or reward providers for healthy outcomes (48%). The areas where major employers expect the legislation to have the greatest impact-reducing the number of uninsured and improving access to care-are issues that are less pressing to companies.
If the legislation increases their healthcare costs as anticipated, most employers (88%) say they'll pass any cost increases on to employees and reduce their health benefits and programs (74%). For the moment, however, most companies are focused on educating senior executives about the impact of reform and modeling its anticipated impact on their organizations.
Stone says employers have to start crunching numbers to include the value of healthcare benefits on their W2s.
She also expects several trends to accelerate. Employers will move toward low cost plans, measuring return on investment, and plans that emphasize consumer behavior. There will be a further reduction in the number of employers offering retiree coverage.
Respondents anticipate the same: more than half expect the number of large employers adopting total replacement consumer-directed health plans-such as health savings accounts (HSA) or health reimbursement arrangements (HRA)-to increase, while more than three-quarters say more employers will drop retiree coverage.
As these trends solidify, Stone says employers will need to take a more holistic look at their total benefit packages. While they may whittle away at health benefits to avoid incurring taxes, they're likely to place greater emphasis on other forms of compensation, such as 401(k) contributions and training and development.
"They need to look at what differentiates them and contributes to employee engagement," she says. "Employers who use this as an opportunity to see how healthcare sits in their total rewards package will be in the best position."
-Shelly Reese
Commentary is independent of source data.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More